is januvia a glp-1 drug New Guidelines for Type 2 Diabetes in 2025 All About The Januvia /

Schink M, Konturek PC, Tietz E, Dieterich W, Pinzer TC, Wirtz S, et al

Patients usually need treatment once a month to maintain results

from the Intramural Research Program of the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (ZIA DK075062)

Tesofensine is a highly effective appetite suppressant that reduces cravings and overall food intake by acting on neurotransmitters that regulate hunger

Nevertheless, an immunologically cold and immune-suppressive TME associated with prostate cancer (PCa) has limited the effectiveness of ICIs [165]

Previous investigations have unveiled the multifaceted mechanisms underlying resistance to ADT, immunotherapy and chemotherapy (Table I